Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autonomic and Renal Contributions to Hypertension With ADT
NCT07848828Phase 4Recruiting
- Sponsor
- Virginia Commonwealth University
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 4 trial in prostate cancer (PCa) (3 arms), sponsored by Virginia Commonwealth University. Primary endpoints: Change in cardiovagal baroreflex sensitivity at 9 weeks, Change in blood pressure reactivity to the cold pressor test at 9 weeks and 5 more. Started Aug 2026; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07848828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848828.